1024 related articles for article (PubMed ID: 15364340)
21. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
22. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.
Knudsen CW; Clopton P; Westheim A; Klemsdal TO; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel AS; Omland T
Ann Emerg Med; 2005 Jun; 45(6):573-80. PubMed ID: 15940086
[TBL] [Abstract][Full Text] [Related]
23. [Effects of real-time analysis of brain natriuretic peptide (BNP) on physicians' decision making in outpatient settings].
Hatanaka N; Yamamoto Y; Matsuo S
Rinsho Byori; 2008 Nov; 56(11):961-6. PubMed ID: 19086450
[TBL] [Abstract][Full Text] [Related]
24. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
[TBL] [Abstract][Full Text] [Related]
25. Is B-type natriuretic peptide-guided heart failure management cost-effective?
Morimoto T; Hayashino Y; Shimbo T; Izumi T; Fukui T
Int J Cardiol; 2004 Aug; 96(2):177-81. PubMed ID: 15262031
[TBL] [Abstract][Full Text] [Related]
26. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
27. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
28. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
[TBL] [Abstract][Full Text] [Related]
30. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
Jourdain P; Jondeau G; Funck F; Gueffet P; Le Helloco A; Donal E; Aupetit JF; Aumont MC; Galinier M; Eicher JC; Cohen-Solal A; Juillière Y
J Am Coll Cardiol; 2007 Apr; 49(16):1733-9. PubMed ID: 17448376
[TBL] [Abstract][Full Text] [Related]
31. B-type natriuretic peptide-guided management and outcome in patients with obesity and dyspnea--results from the BASEL study.
Noveanu M; Breidthardt T; Cayir S; Potocki M; Laule K; Mueller C
Am Heart J; 2009 Sep; 158(3):488-95. PubMed ID: 19699875
[TBL] [Abstract][Full Text] [Related]
32. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
33. [Levels of serum brain natriuretic peptide in children with congestive heart failure or with severe pneumonia].
An JD; Zhang YP; Zhou JH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):201-4. PubMed ID: 16787591
[TBL] [Abstract][Full Text] [Related]
34. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
[TBL] [Abstract][Full Text] [Related]
35. [B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea].
Knudsen CW; Westheim A; Omland T
Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2045-8. PubMed ID: 12934128
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
[TBL] [Abstract][Full Text] [Related]
37. Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients.
Christ M; Sharkova Y; Fenske H; Rostig S; Herzum I; Becker HF; Mueller C; Grimm W
Int J Cardiol; 2007 Mar; 116(1):62-9. PubMed ID: 16820230
[TBL] [Abstract][Full Text] [Related]
38. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.
Christ M; Laule-Kilian K; Hochholzer W; Klima T; Breidthardt T; Perruchoud AP; Mueller C
J Am Coll Cardiol; 2006 Nov; 48(9):1808-12. PubMed ID: 17084254
[TBL] [Abstract][Full Text] [Related]
39. [Brain-natriuretic-peptide (BNP) for improvement of the diagnostic determination in a conserving emergency room].
Post F; Peetz D; Knoess P; Rupprecht HJ
Z Kardiol; 2004; 93 Suppl 4():IV31-5. PubMed ID: 15085364
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients.
Safley DM; McCullough PA
Heart Fail Monit; 2003; 4(1):13-20. PubMed ID: 12808480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
